Results of three years' experience with the deoxyuridine suppression test.
D000437:Alcoholism / Q000097:blood; D000743:Anemia, Hemolytic / Q000175:diagnosis; D000747:Anemia, Hypochromic / Q000175:diagnosis; D000927:Anticonvulsants / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003857:Deoxyuridine; D004827:Epilepsy / Q000188:drug therapy; D004912:Erythrocytes / Q000032:analysis; D004913:Erythrocytes, Abnormal; D004920:Erythropoiesis; D005069:Evaluation Studies as Topic; D005492:Folic Acid / Q000097:blood; D005493:Folic Acid Antagonists; D005494:Folic Acid Deficiency / Q000175:diagnosis*; D006801:Humans; D015122:Mercaptopurine / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000627:therapeutic use; D013866:Thioguanine / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D014806:Vitamin B 12 Deficiency / Q000175:diagnosis*
D000927:Anticonvulsants; D005493:Folic Acid Antagonists; D005492:Folic Acid; D014295:Trimethoprim; D015122:Mercaptopurine; D013866:Thioguanine; D013420:Sulfamethoxazole; D001379:Azathioprine; D003857:Deoxyuridine